API Cross Contamination in Multi Product...
Transcript of API Cross Contamination in Multi Product...
1 Biogen | Confidential and Proprietary
API Cross Contamination in Multi
Product Facilities
Barry Ballinger, CIH
Sr. Manager, EHS
HPAPI Conference, Boston MA
July 15, 2015
2 Biogen | Confidential and Proprietary
Guidelines/Regulations
Risk Assessment
ADE determinations
Routes of Cross Contamination
Evaluation of Engineering Controls
Agenda
3 Biogen | Confidential and Proprietary
“The trouble with quotes on the Internet is
that you can never know if they are genuine.”
- Abraham Lincoln
Disclaimer
4 Biogen | Confidential and Proprietary
• The EU published GMP updates for managing the risk of cross contamination
in August 2014 and which became effective March 1, 2015. The new GMPs
call for risk assessments to determine if products can be produced in shared
facilities. Also states that dedicated facilities are required if:
–the risk cannot be adequately controlled by op or tech measures,
–scientific data from the toxicological evaluation does not support a
controllable risk (e.g. allergenic potential from highly sensitizing materials
such as beta lactams) or
–relevant residue limits, derived from the toxicological evaluation, cannot be
satisfactorily determined by a validated analytical method
EU GMPs
5 Biogen | Confidential and Proprietary
Risk-Based Manufacture of Pharmaceutical Products (Risk-
MaPP), September 2010
• This document outlines a process for assessing the risk of cross
contamination and introduced the acceptable daily exposure
(ADE) as a measure of harm from the hazard (the compound) and
the four possible modes of cross contamination in a multiproduct
facility.
ISPE (Risk-MaPP)
6 Biogen | Confidential and Proprietary
• Evaluation of systems to see if cross contamination is controlled
–Sufficient cleaning validation program
–Contained & Controlled processes
• Does another product present a risk of contamination
–High Risk compounds
• Assess risks of your product contaminating others
• Plans/Schedule for ADE/PDE development
Risk Assessment
7 Biogen | Confidential and Proprietary
• ADE = (NOAEL) / (UFC x α x MF)
Calculating an ADE
Modifying Factor: to
compensate for most
sensitive sub populations
α ∶ 𝑝ℎ𝑎𝑟𝑚𝑎𝑐𝑜𝑘𝑖𝑛𝑒𝑡𝑖𝑐 𝑓𝑎𝑐𝑡𝑜𝑟
Similarly, UFHD may be
calculated as follows:
[PD parameter] + 2SD
[PD parameter]
When the lowest clinical dose is
selected as the POD, it’s regarded
as a LOAEL using this approach.
8 Biogen | Confidential and Proprietary
•Assuming you can just do it yourself
•Assuming an ADE is same as an OEL
•Assuming an ADE is a measure of the Risk of Cross Contamination
•Not establishing a cleaning limit
•Having an ADE that is below your cleaning validation detection limit.
•Waiting too long, Dec 1, 2015 is coming
Ways to get it wrong
9 Biogen | Confidential and Proprietary
• Mechanical Transfer: The transfer of material from contaminated
non-product contact surfaces into the product. Particulate
transfer on clothing/feet from operators and equipment alternating
between 2 or more processing areas
Mitigations: Procedures (e.g., gowning control, dedicated shoes,
established traffic flow patterns, equipment wipe down) closed
process and facility controls
Routes of Contamination
10 Biogen | Confidential and Proprietary
• Airborne Sedimentation: Processes that are inherently dusty can
have the potential to spread contamination. Airborne transfer can
only occur if sedimentation takes place onto open product contact
surfaces.
Mitigations: Containment, closed process, segregated areas, and
facility control (e.g., HVAC filtration, pressure differential and
airlocks) Demonstrate effectiveness with IH sampling
Routes of Contamination
11 Biogen | Confidential and Proprietary
• Mix up: inadvertent mistake, human error, leading to a cross
contamination event. Most commonly occurs through labelling,
receipting, line clearance type problems
• Mitigations:
– Labelling
– Batch records
– GMPs, SOPs, quarantine, QC release
– Use of electronic tracking
Routes of Contamination
12 Biogen | Confidential and Proprietary
• Retention: Visual limits have been around for years, even before validated
cleaning limits existed. Many cleaning processes are manual and also use
a visually clean premise in addition to analytical testing to ensure no carry
over contamination.
– Average limit of visual acuity 2 ug/cm2
Mitigations:
–Use of Robust & validated cleaning methods
–Establish a visual residue limit (VRL) within your protocols
–Visual acuity testing for staff
–Dedicated facilities, Disposable technologies
Routes of Contamination
13 Biogen | Confidential and Proprietary
Hierarchy of Controls
Elimination
Avoid the hazard
Engineering
Move the hazard away
Substitution
Reduce the hazard
Administrative
“Procedural-ize” and train to mitigate the
hazard
Protective Equipment
Add a physical barrier to protect against
that hazard
First
Choice
Last Line
of Defense
14 Biogen | Confidential and Proprietary
Performance of Engineering Controls
Control Technology Performance (µg/m3)
General Ventilation 100- 10,000
Local Exhaust (snorkel) 100 – 5000+
Down Flow Booth 25-1000
Dust Caps 100-500
Fume Hood 10-200
Vented Enclosure 1-100
Continuous Liner 1-50
Flexible Isolator 1-10
Rigid Isolator 0.1 -10
Split Butterfly Valve 1-10
High Containment Valves <0.1
Rapid Transfer Port <0.1
15 Biogen | Confidential and Proprietary
15
May Not Always Work
16 Biogen | Confidential and Proprietary
• Chemical Name: Dimethyl Fumarate
• Trade Name: Tecfidera, 120 mg and 240mg oral capsules
• Indication: Relapsing forms of multiple sclerosis
• Pharmacological/Chemical Class: Anti-inflammatory/Nrf2
activators
16
API - Dimethyl fumarate
17 Biogen | Confidential and Proprietary
• Active ingredient in Fumaderm™ (Germany) 1994
• Used historically as anti-fungal and mold inhibitor
• Recognized as an allergenic sensitizer
17
Dimethyl Fumarate - Background
• Numerous cases in Europe/Finland of skin reactions
• 1998 EU ban on use of DMF in furniture
• Other API facts:
Sublimes at room temp
High Kst
Low MIE
Skin sensitizer
18 Biogen | Confidential and Proprietary
Dispense, Blending, Milling & Compression
Isolator w/ N2 inertion
High containment split butterfly valves
Milling w/ N2 inertion
Pressure cascade process rooms
Misting shower
Ex rated dust collection system
Airlock Breathing air supply
19 Biogen | Confidential and Proprietary
Engineering Controls
20 Biogen | Confidential and Proprietary
Ventilated Enclosures
• Ideal for Lab Scale operations
• Designed to contain powders/dusts
• Can be Exhausted or Recirculated
• HEPA & Carbon filtration options
• Containment in the 1-10ug/m3 range
21 Biogen | Confidential and Proprietary
21
Fume Hood Dispensing
• Operator can lean into the
fume hood
• Technique dependant
• Changes to process aren't
easy to accomodate
• May reach <10ug/m3 with
good technique
22 Biogen | Confidential and Proprietary
• Inexpensive: $500 to 6K
• Custom LEV at point of source can reduce dust levels
• Very technique dependent
• Not effective for high risk compounds
• Always-on; energy wasters
Local Exhaust Ventilation
23 Biogen | Confidential and Proprietary
• Operator in the path of contamination
• Containment screen option improves containment
• 25 to 1000µg/m3 containment
• Variable widths, depths and heights
• Recirculatory or Single Pass
• Higher energy cost to run
• 100K and up
Downflow Booth
24 Biogen | Confidential and Proprietary
• Retrofitted to existing equipment
• Cheap
20k+ for passive
50K+ for active
1K for flexi canopy
• 1-10µg/m3
• Quick
• Robustness?
• Short to Mid term fix
• Ergonomics issues
Flexible Isolators
25 Biogen | Confidential and Proprietary
• Not dependant on technique
• Point of transfer, weak point
• Long lead time
• Excellent containment
• Long term fix
• Ergonomics issues?
• Costly, 200k+
Rigid Isolators
26 Biogen | Confidential and Proprietary
26
Continuous Liner
& Crimp
• Used for pack-off, waste, dust collectors
• Anti static bags
• 1 - 50µg/m3
• Variety of thickness bags
• Cassette & Hardware 5k+
• Roll of liners $200 - 500
27 Biogen | Confidential and Proprietary
27
Split Butterfly
Valves
• Closed transfer
• Safety sensors
• Pin guided
• Grounded
• Auto or Ergo Handles
• <1ug/m3
• Costly (10-30K) / valve
28 Biogen | Confidential and Proprietary
• Alpha/Beta configuration
• Variable sizes
• Containment to <0.1µg/m3
• Limited to small size transfers
• ~10k +
Rapid Transfer Ports
29 Biogen | Confidential and Proprietary
Wash in Place/ Clean in Place
• CIP: Cleaning of interior surfaces without need for equipment disassembly.
Is usually automated with a validated system that has a computer user
interface with programmable recipes for cleaning.
• WIP: A combination of manual and automated washing of equipment which
may require some level of disassembly for complete washing.
Spray balls
30 Biogen | Confidential and Proprietary
Fogging/Misting Shower
• Fogging and or Mist shower
• Programmable timing
• PPE waste disposal
• Ventilated chamber
• Lighting/Benches
• ~40k+
31 Biogen | Confidential and Proprietary
• Know your process risks from start to finish
• Utilize your network and professional services
• Contain at the source for operations and for cleaning operations
• Containment is just one piece of the puzzle
• Avoid technique dependant systems
• Don’t forget material transfers
• Aspire to be PPE free
Take Away Messages